(NASDAQ:FBLG), HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the filing of a Phase 1/2 Investigational New Drug (IND) application […]

(NASDAQ:ICUI), SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medical's presentation will

Danish Entrepreneur Shares 33-Year China Journey at Jiaxing Opening-Up Symposium GlobeNewswire December 31, 2025 JIAXING, China, Dec. 31, 2025 (GLOBE NEWSWIRE) — On December 10, 2025, at a high-level symposium on high-standard opening-up and high-quality development held in Jiaxing, China, a foreign entrepreneur drew wide attention by sharing his “Jiaxing story” in fluent Chinese. He

HMG Strategy Unveils 2026 C-Level Technology Leadership Summit Series: Empowering C-Suite Leaders to Drive Growth, AI Innovation, and Cybersecurity Excellence GlobeNewswire December 31, 2025 FAIRFIELD, Conn., Dec. 31, 2025 (GLOBE NEWSWIRE) — HMG Strategy, the world's leading digital platform for CIO and CISO leadership, is proud to announce its highly anticipated 2026 Global C-Level Technology

Trump Media Announces Plans to Distribute Digital Tokens to DJT Shareholders GlobeNewswire December 31, 2025 SARASOTA, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) — Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) (“Trump Media”), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, today announced plans

FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis GlobeNewswire December 31, 2025 HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures

ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 31, 2025 SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan

(Other OTC:HYOR),(OTC US:HYOR), HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCID: HYOR), a clean-energy technology company, today announced the successful completion of the Factory Acceptance Test (FAT) for its 500kW Organic Rankine Cycle (ORC) turbine, which is now being prepared for shipment to Camsan Ordu, a customer project in Turkey. The FAT was

HyOrc Completes Factory Acceptance Test of 500kw ORC Turbine for International Customer GlobeNewswire December 31, 2025 HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCID: HYOR), a clean-energy technology company, today announced the successful completion of the Factory Acceptance Test (FAT) for its 500kW Organic Rankine Cycle (ORC) turbine, which is now being prepared

(TSX-V:RFX), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) — Reeflex Solutions Inc. (TSXV: RFX) (“Reeflex” or the “Company“) announces that, further to its announcement on December 17, 2025, the Alberta Securities Commission (the “ASC“), as principal regulator of the Company, has